Innovative Medicines Fund: Patients get earlier access to cutting-edge treatments on NHS
NHS launches £340 million Innovative Medicines Fund, giving potentially life-saving and cutting-edge treatments to patients in England.
NHS launches £340 million Innovative Medicines Fund, giving potentially life-saving and cutting-edge treatments to patients in England.
As part of the innovating healthcare strategy, Professor Mike Bewick, Former Deputy National Medical Doctor at NHS England, sits down with Sasha Karakusevic at NHS Horizons, Steve Mann, Director at 4Global and Lord James Bethell, Former Minister for the Innovation Department of Health and Social Care to discuss the UK’s obesity roadmap.
Health ministers from the G7 countries have agreed a ‘pandemic pact’ to prevent further global health crises following the coronavirus pandemic. Will the landmark agreement ensure the world is prepared for the future?
New data shows that 1.2 million additional NHS patients are currently eligible for vital medicines but are missing out. The need for maximum innovation in the health and life sciences sector grows.
A new 10-year plan to tackle dementia and boost funding into research to better understand neurodegenerative diseases has been announced by government,.
Antimicrobial resistance (AMR) is a global threat to public health which fails to receive the attention warranted for the danger posed in coming years. As the Government seeks to push UK life sciences to world-leading status, we examine what action plan is in place and what can be done.
The NHS is a year ahead of schedule in rolling out mental health teams in schools and colleges across the country. Using innovative methods such
4Global and NHS Horizons have published a new report on physical activity and innovation. With severe government cuts to obesity services and norms of physical inactivity following Covid-19, can these approaches go far enough to fix the national health crisis?
In this guest article, our authors talk about how health data systems can be changed to drive continuous improvement
With significant supply shortages and prescription delays, millions of women dealing with symptoms of menopause are struggling to access the treatment they need.
Current NHS waiting lists are pushing more people to pay for private care as the nation’s health service struggles following the Covid-19 pandemic.
Medicines regulator National Institute for Health and Care Excellence (NICE) has announced two new antimicrobial drugs – cefiderocol and ceftazidime–avibactam – are close to becoming
Receive our latest insights, future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights and all future journals as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.
Receive our latest insights as soon as they are published and get invited to our exclusive events and webinars.
We respect your privacy and will not share your email address with any third party. Your personal data will be collected and handled in accordance with our Privacy Policy.